Abstract 1646: Development of small-molecule HPK1 inhibitors to unleash tumor-specific T cell responses
Katibah, George, Ohol, Yamini, Bucher, Cyril, Adusumilli, Lavanya, Kaveri, Deepika, Robles, Omar, Sun, Michael, Cho, Cynthia, Milestone, Heather, Ames, Rachel, Jacobson, Scott, Nebalasca, Dan, Gomez- Guagua, Justy, Sanchez, Jerick, Grandcolas, Molly, Wong, Steve, Brovarney, Martin, Ramana, Chandru, Zaw, Thant, Nguyen, Lan, Tivitmahaisoon, Parcharee, Ng, Andrew, Ma, Anqi, Gomez, Blanca, Ko, Michelle, Leger, Paul, Jackson, Jeffrey, Shibuya, Grant, Shakhmin, Anton, Bradford, Delia, Xu, Mengshu, Zibinsky, Mikhail, Poon, Daniel, Wustrow, David, Kassner, Paul, Brockstedt, Dirk
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article